Literature DB >> 16292509

Nociceptive response and adenine nucleotide hydrolysis in synaptosomes isolated from spinal cord of hypothyroid rats.

Alessandra Nejar Bruno1, Daniela Pochmann, Felipe Klein Ricachenevsky, Fernanda Urruth Fontella, Carla Denise Bonan, Carla Dalmaz, Maria Luiza M Barreto-Chaves, João José Freitas Sarkis.   

Abstract

Purinergic system exerts a significant influence on the modulation of pain pathways at the spinal site. Adenosine has antinociceptive properties in experimental and clinical situations, while ATP exerts pronociceptive actions in different pain models. In this study we investigated the hydrolysis of ATP to adenosine in synaptosomes from spinal cord in parallel with the nociceptive response of rats at different ages after hypothyroidism induction. Hypothyroidism elicited a significant increase in AMP hydrolysis to adenosine in synaptosomes from spinal cord of rats subjected to neonatal hypothyroidism and in 420-day-old rats submitted to thyroidectomy. Accordingly, these rats presented an analgesic response as a consequence of hypothyroidism. In contrast, the ATP hydrolysis was decreased in the spinal cord of 60-day-old hypothyroid rats in parallel with a significant increase in nociceptive response. These results indicate the involvement of adenine nucleotides in the control of the hypothyroidism-induced nociceptive response during development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16292509     DOI: 10.1007/s11064-005-7867-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

Review 2.  Thyroid hormone-induced plasticity in the adult rat brain.

Authors:  L Calzà; L Aloe; L Giardino
Journal:  Brain Res Bull       Date:  1997       Impact factor: 4.077

Review 3.  Role of adenosine as a modulator of synaptic activity in the central nervous system.

Authors:  J M Brundege; T V Dunwiddie
Journal:  Adv Pharmacol       Date:  1997

4.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

5.  Age-dependent changes of presynaptic neuromodulation via A1-adenosine receptors in rat hippocampal slices.

Authors:  B Sperlágh; G Zsilla; M Baranyi; A Kékes-Szabó; E S Vizi
Journal:  Int J Dev Neurosci       Date:  1997-10       Impact factor: 2.457

Review 6.  Adenosine for pain control.

Authors:  A Sollevi
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1997

7.  Adenosine and neuropathic pain.

Authors:  R Guieu; J C Peragut; P Roussel; H Hassani; F Sampieri; G Bechis; R Gola; H Rochat
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

8.  Observations on the algogenic actions of adenosine compounds on the human blister base preparation.

Authors:  Tirza Bleehen; C A Keele
Journal:  Pain       Date:  1977-08       Impact factor: 6.961

9.  Analgesia induced by exposure to a novel environment in rats: effect of concurrent and post-training stressful stimulation.

Authors:  C A Netto; B Siegfried; I Izquierdo
Journal:  Behav Neural Biol       Date:  1987-09

10.  Action of externally applied ATP on rat reticulospinal vasomotor neurons.

Authors:  M K Sun; C Wahlestedt; D J Reis
Journal:  Eur J Pharmacol       Date:  1992-11-24       Impact factor: 4.432

View more
  3 in total

Review 1.  Purinergic signaling in thyroid disease.

Authors:  Ying Le; Donghui Lu; Meng Xue
Journal:  Purinergic Signal       Date:  2022-03-26       Impact factor: 3.765

Review 2.  Headache attributed to hypothyroidism.

Authors:  Deborah E Tepper; Stewart J Tepper; Fred D Sheftell; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2007-08

3.  New approaches to thyroid hormones and purinergic signaling.

Authors:  Gabriel Fernandes Silveira; Andréia Buffon; Alessandra Nejar Bruno
Journal:  J Thyroid Res       Date:  2013-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.